NRLCX
Price
$48.70
Change
+$0.29 (+0.60%)
Updated
Jul 3 closing price
Net Assets
8.34B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

NRLCX vs VVIAX

Header iconNRLCX vs VVIAX Comparison
Open Charts NRLCX vs VVIAXBanner chart's image
Neuberger Berman Large Cap Value R6
Price$48.70
Change+$0.29 (+0.60%)
VolumeN/A
Net Assets8.34B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
NRLCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NRLCX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRLCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. NRLCX (8.34B). NRLCX (2.27) and VVIAX (2.18) have matching dividends . NRLCX was incepted earlier than VVIAX: NRLCX (6 years) vs VVIAX (25 years). NRLCX (0.51) is less costly to investors than VVIAX (0.05). NRLCX is a more actively managed with annual turnover of: 81.00 vs. VVIAX (9.00). NRLCX has a lower initial minimum investment than VVIAX: NRLCX (0) vs VVIAX (3000). NRLCX annual gain was more profitable for investors over the last year : 12.91 vs. VVIAX (12.03). NRLCX return over 5 years is better than : 90.45 vs. VVIAX (80.13).
NRLCXVVIAXNRLCX / VVIAX
Total Expense Ratio0.510.051,020%
Annual Report Gross Expense Ratio0.510.051,020%
Fund Existence6 years25 years-
Gain YTD8.6816.198140%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.34B189B4%
Annual Yield % from dividends2.272.18104%
Returns for 1 year12.9112.03107%
Returns for 3 years27.0135.1777%
Returns for 5 years90.4580.13113%
Returns for 10 yearsN/A115.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.